🚨 BREAKTHROUGH: Doctors in Houston Report Complete Disappearance of Aggressive Liver Cancer in a 3-Year-Old Using a Personalized Immunotherapy Made From the Child’s Own Cells No Cancer Detected One Year Late
November 4, 2026 at 1:18 PM
🚨 BREAKTHROUGH: Doctors in Houston Report Complete Disappearance of Aggressive Liver Cancer in a 3-Year-Old Using a Personalized Immunotherapy Made From the Child’s Own Cells No Cancer Detected One Year Late
ICU admissions in the last year. Immunotherapy has kept me alive and controlled the cancer. But if I continue, I risk potential further toxicity from immunotherapy while I'm recovering from surgery, pneumonia and persistent atrial fibrillation. I want to avoid putting my body through another...
November 5, 2026 at 12:14 PM
ICU admissions in the last year. Immunotherapy has kept me alive and controlled the cancer. But if I continue, I risk potential further toxicity from immunotherapy while I'm recovering from surgery, pneumonia and persistent atrial fibrillation. I want to avoid putting my body through another...
It turns out that chemotherapy and immunotherapy can actually reinforce each other, but you have to get the timing right:
Chemotherapy Actually Helps Immunotherapy in Cancer
www.science.org
November 3, 2026 at 8:11 PM
It turns out that chemotherapy and immunotherapy can actually reinforce each other, but you have to get the timing right:
Why do some patients with obesity respond better to immunotherapy? Not the fat — the food. Twelve diets, a 48-hour switch, and one refractory patient's stool with two opposite fates reveal diet as the switch that decides whether anti-PD-1 works.
doi.org/10.59717/j.x...
#gutmicrobiome #immunotherapy
doi.org/10.59717/j.x...
#gutmicrobiome #immunotherapy
November 7, 2026 at 12:32 AM
Why do some patients with obesity respond better to immunotherapy? Not the fat — the food. Twelve diets, a 48-hour switch, and one refractory patient's stool with two opposite fates reveal diet as the switch that decides whether anti-PD-1 works.
doi.org/10.59717/j.x...
#gutmicrobiome #immunotherapy
doi.org/10.59717/j.x...
#gutmicrobiome #immunotherapy
Congratulations to ApolloBio Corp and the investigators presenting Phase 3 VGX-3100 data at #SITC2026 today! The trial in HPV-16/18 cervical HSIL met its primary endpoint, combining lesion regression with HPV clearance. A big step for DNA immunotherapy.
youtu.be/awjdYz6WQ8k
#HPV #Immunotherapy
youtu.be/awjdYz6WQ8k
#HPV #Immunotherapy
David B Weiner's DNA Immunotherapy Treatment, VGX-3100, Succeeds in Phase 3 Clinical Trials
Congratulations to Wistar’s Director of the Vaccine & Immunotherapy Center and co-founder of Inovio, David B. Weiner, whose DNA immunotherapy medicine, VGX-3...
youtu.be
November 6, 2026 at 8:00 PM
Congratulations to ApolloBio Corp and the investigators presenting Phase 3 VGX-3100 data at #SITC2026 today! The trial in HPV-16/18 cervical HSIL met its primary endpoint, combining lesion regression with HPV clearance. A big step for DNA immunotherapy.
youtu.be/awjdYz6WQ8k
#HPV #Immunotherapy
youtu.be/awjdYz6WQ8k
#HPV #Immunotherapy
So, I have a very significant decision to make. I haven't had my immunotherapy treatment for a few months now because of major surgery. The funding for this runs out soon and the rules are I'm not allowed to reapply. An additional problem is whether it is medically safe for me to resume as two...
November 5, 2026 at 12:12 PM
So, I have a very significant decision to make. I haven't had my immunotherapy treatment for a few months now because of major surgery. The funding for this runs out soon and the rules are I'm not allowed to reapply. An additional problem is whether it is medically safe for me to resume as two...
🚀 Cancer immunotherapy is getting smarter and more precise.
At #FallingWalls2026, Christian Seitz (DKTK), Larysa Baraban (HZDR) and Amy Lin (ARPA-H) discuss how to steer immune cells against cancer and monitor their effects in real time.
👉 t1p.de/vuze8
#CancerResearch #Immunotherapy #DZG
At #FallingWalls2026, Christian Seitz (DKTK), Larysa Baraban (HZDR) and Amy Lin (ARPA-H) discuss how to steer immune cells against cancer and monitor their effects in real time.
👉 t1p.de/vuze8
#CancerResearch #Immunotherapy #DZG
November 6, 2026 at 11:33 AM
🚀 Cancer immunotherapy is getting smarter and more precise.
At #FallingWalls2026, Christian Seitz (DKTK), Larysa Baraban (HZDR) and Amy Lin (ARPA-H) discuss how to steer immune cells against cancer and monitor their effects in real time.
👉 t1p.de/vuze8
#CancerResearch #Immunotherapy #DZG
At #FallingWalls2026, Christian Seitz (DKTK), Larysa Baraban (HZDR) and Amy Lin (ARPA-H) discuss how to steer immune cells against cancer and monitor their effects in real time.
👉 t1p.de/vuze8
#CancerResearch #Immunotherapy #DZG
I did immunotherapy, too. It’s real love
November 5, 2026 at 6:22 PM
I did immunotherapy, too. It’s real love
🧬 Can a #faecaltransplant restore the effectiveness of #immunotherapy for #livercancer?
An interdisciplinary research team led by #MedUniVienna study investigated whether the transfer of #gutbacteria can help when immunotherapy is no longer effective.
📰 @natcomms.nature.com
Read more! ⬇️
An interdisciplinary research team led by #MedUniVienna study investigated whether the transfer of #gutbacteria can help when immunotherapy is no longer effective.
📰 @natcomms.nature.com
Read more! ⬇️
Liver cancer: Faecal microbiota transplantation may enable a response to immunotherapy
Further details!
www.meduniwien.ac.at
November 4, 2026 at 12:29 PM
🧬 Can a #faecaltransplant restore the effectiveness of #immunotherapy for #livercancer?
An interdisciplinary research team led by #MedUniVienna study investigated whether the transfer of #gutbacteria can help when immunotherapy is no longer effective.
📰 @natcomms.nature.com
Read more! ⬇️
An interdisciplinary research team led by #MedUniVienna study investigated whether the transfer of #gutbacteria can help when immunotherapy is no longer effective.
📰 @natcomms.nature.com
Read more! ⬇️
Someone nominate Professor Long for the Nobel Prize in Medicine. She's earned it IMO. www.sydney.edu.au/news-opinion... #Nobel #Melanoma
World-first personalised therapeutic cancer vaccine cuts risk of melanoma recurrence
In a world-first international trial, adding a type of personalised therapeutic cancer vaccine made from an individual patient’s own tumours to immunotherapy after surgery for high-risk melanoma, redu...
www.sydney.edu.au
November 5, 2026 at 12:25 AM
Someone nominate Professor Long for the Nobel Prize in Medicine. She's earned it IMO. www.sydney.edu.au/news-opinion... #Nobel #Melanoma
My husband @jebushchrist.bsky.social is doing his last immunotherapy treatment today and is still cancer free and he had probably <5% chance making it 5 years before this new chemo came out 2 years ago. I am SO EXCITED about the future of cancer treatments.
November 4, 2026 at 2:51 PM
My husband @jebushchrist.bsky.social is doing his last immunotherapy treatment today and is still cancer free and he had probably <5% chance making it 5 years before this new chemo came out 2 years ago. I am SO EXCITED about the future of cancer treatments.
A three-year-old boy’s liver cancer has been in complete remission for a year after an experimental CAR-T immunotherapy. Researchers engineered the boy’s own T cells to target a protein called glypican-3 on his hepatoblastoma cells. buff.ly/pzm3veU
#ShareGoodNewsToo
#ShareGoodNewsToo
Complete Regression of Hepatoblastoma after Interleukin-15– and Interleukin-21–Coexpressing CAR T-Cell Therapy | NEJM
A 3-year-old boy with chemotherapy-resistant metastatic hepatoblastoma had complete regression lasting at least 12 months after two infusions of glypican-3–specific CAR T cells coexpressing interle...
buff.ly
November 6, 2026 at 1:50 PM
A three-year-old boy’s liver cancer has been in complete remission for a year after an experimental CAR-T immunotherapy. Researchers engineered the boy’s own T cells to target a protein called glypican-3 on his hepatoblastoma cells. buff.ly/pzm3veU
#ShareGoodNewsToo
#ShareGoodNewsToo
This week's Research Highlight💫: Restoring the flow: doi.org/10.1172/jci....
Cain et al. unravel drivers of aberrant tumor vasculature and show that arresting the cell cycle in endothelial cells promotes tumor vessel maturation/function, reduces hypoxia, and cooperates with immunotherapy.
Cain et al. unravel drivers of aberrant tumor vasculature and show that arresting the cell cycle in endothelial cells promotes tumor vessel maturation/function, reduces hypoxia, and cooperates with immunotherapy.
November 9, 2026 at 1:00 AM
This week's Research Highlight💫: Restoring the flow: doi.org/10.1172/jci....
Cain et al. unravel drivers of aberrant tumor vasculature and show that arresting the cell cycle in endothelial cells promotes tumor vessel maturation/function, reduces hypoxia, and cooperates with immunotherapy.
Cain et al. unravel drivers of aberrant tumor vasculature and show that arresting the cell cycle in endothelial cells promotes tumor vessel maturation/function, reduces hypoxia, and cooperates with immunotherapy.
hringdi endurtekið í deildina og náði að koma öllu á hreint og held planinu sem að var fyrirætlað!
svo jeij fer ekki aftur í 'chemotherapy'
í staðin fæ ég öruglega að byrja á 'immunotherapy' á afmælisdaginn minn, enn sú veisla!
svo jeij fer ekki aftur í 'chemotherapy'
í staðin fæ ég öruglega að byrja á 'immunotherapy' á afmælisdaginn minn, enn sú veisla!
November 4, 2026 at 4:14 PM
hringdi endurtekið í deildina og náði að koma öllu á hreint og held planinu sem að var fyrirætlað!
svo jeij fer ekki aftur í 'chemotherapy'
í staðin fæ ég öruglega að byrja á 'immunotherapy' á afmælisdaginn minn, enn sú veisla!
svo jeij fer ekki aftur í 'chemotherapy'
í staðin fæ ég öruglega að byrja á 'immunotherapy' á afmælisdaginn minn, enn sú veisla!
Immunotherapy has begun, as a way to sooth progress, but it’s moved on to liver and lymph.
12 months, tops.
12 months, tops.
November 6, 2026 at 3:57 AM
Immunotherapy has begun, as a way to sooth progress, but it’s moved on to liver and lymph.
12 months, tops.
12 months, tops.
We're all set up and ready to see you! Witness the latest in single cell and spatial multiomics at booth #1101.
#SITC26 #SingleCell #SpatialBiology #Immunotherapy
#SITC26 #SingleCell #SpatialBiology #Immunotherapy
November 5, 2026 at 8:08 PM
We're all set up and ready to see you! Witness the latest in single cell and spatial multiomics at booth #1101.
#SITC26 #SingleCell #SpatialBiology #Immunotherapy
#SITC26 #SingleCell #SpatialBiology #Immunotherapy
Immunotherapy is changing how we think about treating cancer. I’m interested in following the research and learning where the next breakthroughs may lead.
November 9, 2026 at 12:45 AM
Immunotherapy is changing how we think about treating cancer. I’m interested in following the research and learning where the next breakthroughs may lead.
Second immunotherapy, completed it mate.
Now to restart in 6 months time
Now to restart in 6 months time
November 2, 2026 at 5:08 PM
Second immunotherapy, completed it mate.
Now to restart in 6 months time
Now to restart in 6 months time
California voters, who rejected a wealth tax, have supported an $8.4 billion bonds to fund immunology and immunotherapy research that is basically a direct benefit to one center in UCLA. A curious way to counter federal research cuts.
November 4, 2026 at 5:31 PM
California voters, who rejected a wealth tax, have supported an $8.4 billion bonds to fund immunology and immunotherapy research that is basically a direct benefit to one center in UCLA. A curious way to counter federal research cuts.
He's claiming STEVEN MILLER said no other primate than Humans have to contend w/ cancer in the young & rampant cancer rates??
Thanks for reaffirming Miller doesn't have a fuking clue what he's talking about - be it law or biology or epidemiology or onc...
jitc.bmj.com/content/11/1...
Utter IDIOTS
Thanks for reaffirming Miller doesn't have a fuking clue what he's talking about - be it law or biology or epidemiology or onc...
jitc.bmj.com/content/11/1...
Utter IDIOTS
Spontaneous, naturally occurring cancers in non-human primates as a translational model for cancer immunotherapy
The complexity of cancer immunotherapy (CIT) demands reliable preclinical models to successfully translate study findings to the clinics. Non-human primates (NHPs; here referring to rhesus and cynomol...
jitc.bmj.com
November 8, 2026 at 4:19 PM
He's claiming STEVEN MILLER said no other primate than Humans have to contend w/ cancer in the young & rampant cancer rates??
Thanks for reaffirming Miller doesn't have a fuking clue what he's talking about - be it law or biology or epidemiology or onc...
jitc.bmj.com/content/11/1...
Utter IDIOTS
Thanks for reaffirming Miller doesn't have a fuking clue what he's talking about - be it law or biology or epidemiology or onc...
jitc.bmj.com/content/11/1...
Utter IDIOTS
Frazer's Foundations of Immunotherapy
The complete immunotherapy reference from basic science to clinical application
Immunotherapy has transformed treatment approaches for cancer, autoimmune diseases, and infectious conditions, yet no single…
View Book #Subteron #HealthAndPandemics
The complete immunotherapy reference from basic science to clinical application
Immunotherapy has transformed treatment approaches for cancer, autoimmune diseases, and infectious conditions, yet no single…
View Book #Subteron #HealthAndPandemics
Frazer's Foundations of Immunotherapy
The complete immunotherapy reference from basic science to clinical application
Immunotherapy has transformed treatment approaches for cancer, autoimmune diseases, and infectious conditions, yet no single resource has unified its foundational immunology with advanced clinical applications.
bookshop.org
November 6, 2026 at 4:25 PM
Frazer's Foundations of Immunotherapy
The complete immunotherapy reference from basic science to clinical application
Immunotherapy has transformed treatment approaches for cancer, autoimmune diseases, and infectious conditions, yet no single…
View Book #Subteron #HealthAndPandemics
The complete immunotherapy reference from basic science to clinical application
Immunotherapy has transformed treatment approaches for cancer, autoimmune diseases, and infectious conditions, yet no single…
View Book #Subteron #HealthAndPandemics
